503 results on '"Dahan, Arik"'
Search Results
2. Selective COX-2 inhibitors after bariatric surgery: Celecoxib, etoricoxib and etodolac post-bariatric solubility/dissolution and pharmacokinetics
3. Carbamazepine Therapy After Bariatric Surgery: Eight Sleeve Gastrectomy Cases and Review of the Literature
4. Quantification of Etoricoxib in Low Plasma Volume by UPLC-PDA and Application to Preclinical Pharmacokinetic Study
5. Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
6. Can Consultation by a Clinical Pharmacist Prevent Morbidity and Mortality in Patients Undergoing Bariatric Surgery?
7. Hypothyroidism and levothyroxine therapy following bariatric surgery: a systematic review, meta-analysis, network meta-analysis, and meta-regression
8. Influence of Bariatric Surgery on Levetiracetam Clinical Effectiveness: Case Series
9. Solubility-enabling formulations for oral delivery of lipophilic drugs: considering the solubility-permeability interplay for accelerated formulation development
10. An Emerging Strategy for Neuroinflammation Treatment: Combined Cannabidiol and Angiotensin Receptor Blockers Treatments Effectively Inhibit Glial Nitric Oxide Release
11. Towards Effective Antiviral Oral Therapy: Development of a Novel Self-Double Emulsifying Drug Delivery System for Improved Zanamivir Intestinal Permeability
12. Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies
13. Oral levothyroxine therapy postbariatric surgery: Biopharmaceutical aspects and clinical effects
14. Segmental-Dependent Intestinal Drug Permeability: Development and Model Validation of In Silico Predictions Guided by In Vivo Permeability Values
15. Lipidic Prodrugs for Drug Delivery: Opportunities and Challenges
16. Lithium Toxicity with Severe Bradycardia Post Sleeve Gastrectomy: a Case Report and Review of the Literature
17. Phospholipid-drug conjugates as a novel oral drug targeting approach for the treatment of inflammatory bowel disease
18. Solubility-enabling formulations for oral delivery of lipophilic drugs: considering the solubility-permeability interplay for accelerated formulation development
19. The Complexity of Bariatric Patient's Pharmacotherapy: Sildenafil Biopharmaceutics and Pharmacokinetics before vs. after Gastric Sleeve/Bypass.
20. Segmental-dependent permeability throughout the small intestine following oral drug administration: Single-pass vs. Doluisio approach to in-situ rat perfusion
21. Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo
22. Computational modeling and in-vitro/in-silico correlation of phospholipid-based prodrugs for targeted drug delivery in inflammatory bowel disease
23. Segmental-Dependent Drug Absorption and Delivery: The Intestinal Tract
24. Segmental-Dependent Drug Absorption and Delivery: The Stomach
25. Solubility, Permeability, and Their Interplay
26. The use of captisol (SBE7-β-CD) in oral solubility-enabling formulations: Comparison to HPβCD and the solubility–permeability interplay
27. Head-To-Head Comparison of Different Solubility-Enabling Formulations of Etoposide and Their Consequent Solubility–Permeability Interplay
28. The biopharmaceutics of successful controlled release drug product: Segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tract
29. In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: Investigation of the single-pass vs. the Doluisio experimental approaches
30. Enabling oral delivery of antiviral drugs: Double emulsion carriers to improve the intestinal absorption of zanamivir
31. Targeted Prodrugs in Oral Drug Delivery
32. Advantageous Solubility-Permeability Interplay When Using Amorphous Solid Dispersion (ASD) Formulation for the BCS Class IV P-gp Substrate Rifaximin: Simultaneous Increase of Both the Solubility and the Permeability
33. Pharmacological effects of vitamin D and its analogs: recent developments
34. The complexity of intestinal permeability: Assigning the correct BCS classification through careful data interpretation
35. A mechanistic approach to understanding oral drug absorption in pediatrics: an overview of fundamentals
36. Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Codeine Phosphate
37. Active intestinal drug absorption and the solubility-permeability interplay
38. Transporter- and Enzyme-Targeted Prodrugs for Improved Oral Drug Delivery
39. Concomitant solubility-permeability increase: Vitamin E TPGS vs. amorphous solid dispersion as oral delivery systems for etoposide
40. The interaction of nifedipine with selected cyclodextrins and the subsequent solubility–permeability trade-off
41. Antiallergic Treatment of Bariatric Patients: Potentially Hampered Solubility/Dissolution and Bioavailability of Loratadine, but Not Desloratadine, Post-Bariatric Surgery
42. The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of Minoxidil
43. 371: PHOSPHOLIPID PRODRUG DECREASES INFLAMMATORY MARKERS IN HUMAN INTESTINAL EXPLANTS: PROOF OF CONCEPT FOR AN INFLAMMATION-TARGETED DRUG DELIVERY STRATEGY FOR THE TREATMENT OF IBD
44. Accounting for the solubility–permeability interplay in oral formulation development for poor water solubility drugs: The effect of PEG-400 on carbamazepine absorption
45. PLA2-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy
46. Prodrug-Based Targeting Approach for Inflammatory Bowel Diseases Therapy: Mechanistic Study of Phospholipid-Linker-Cyclosporine PLA2-Mediated Activation
47. Pathways for Dolutegravir Transformation from a Daily Oral to a Once-a-Year Parenteral Medicine
48. Lamotrigine therapy in patients after bariatric surgery: Potentially hampered solubility and dissolution
49. Managing the Unpredictable: Mechanistic Analysis and Clinical Recommendations for Lamotrigine Treatment after Bariatric Surgery
50. Investigation of the Drug Dose, Alongside the Solubility, the Permeability, and their Interplay, as Key Factors in Formulation Development for Oral Lipophilic Drugs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.